Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope
Ovarian cancer is a leading cause of cancer-related deaths among women, with platinum resistance posing a significant challenge. Conventional therapies often fail in these cases, highlighting the urgent need for novel treatment approaches. Immunotherapy has emerged as a promising strategy, offering...
Saved in:
Main Authors: | Jan Brancewicz, Irena Barbara Padzińska-Pruszyńska, Małgorzata Kubiak, Paulina Kucharzewska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/13/995 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of the Role of the Tumor Microenvironment in Ovarian Cancer (MICO): A Prospective Monocentric Trial
by: Martina Arcieri, et al.
Published: (2025-06-01) -
FAM111B Overexpression and Immune Cell Infiltration: Implications for Ovarian Cancer Immunotherapy
by: Wanying Li, et al.
Published: (2025-05-01) -
Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy
by: Haozhe Piao, et al.
Published: (2025-07-01) -
Tumor microenvironment-responsive nanoplatforms for enhanced cancer immunotherapy: Advances and synergistic strategies
by: Jie Wu, et al.
Published: (2025-12-01) -
Immune organoid for cancer immunotherapy
by: Xiao-He Wang, et al.
Published: (2025-07-01)